| scholarly article | Q13442814 |
| P2093 | author name string | Asifa Nazir | |
| P2860 | cites work | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 |
| Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan | Q33388111 | ||
| Multidrug resistant Acinetobacter | Q33711902 | ||
| The Lowbury lecture: behaviour in infection control | Q34346026 | ||
| Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa | Q34555131 | ||
| The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa | Q34581987 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| AcinetobacterOutbreaks, 1977–2000 | Q35119005 | ||
| Acinetobacter septicemia in neonates admitted to intensive care units | Q35199332 | ||
| Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features | Q35369996 | ||
| Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality | Q51024117 | ||
| Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. | Q53216475 | ||
| Acinetobacter sepsis in newborns. | Q54128006 | ||
| Acinetobacter sepsis in neonates. | Q54225586 | ||
| Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report | Q63859723 | ||
| Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups | Q77805594 | ||
| Acinetobacter septicaemia in neonates | Q80646590 | ||
| Acinetobacter spp. - an emerging pathogen in neonatal septicemia in Amritsar | Q82677430 | ||
| Antimicrobial drug resistance: "Prediction is very difficult, especially about the future" | Q36006748 | ||
| Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
| Clinical impact and pathogenicity of Acinetobacter. | Q36282248 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces | Q36541849 | ||
| Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 | ||
| Microbiological profile of neonatal septicemia in a pediatric care hospital in Delhi. | Q36642446 | ||
| Outcomes of Acinetobacter baumannii infection in critically ill burned patients. | Q36757236 | ||
| Mortality audit of neonatal sepsis secondary to acinetobacter | Q36771731 | ||
| Neonatal morbidity and mortality after elective cesarean delivery | Q36777674 | ||
| Acinetobacter: an old friend, but a new enemy | Q37584808 | ||
| Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance | Q37667216 | ||
| Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children | Q38035088 | ||
| Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. | Q42637997 | ||
| Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia | Q42908865 | ||
| Neonatal septicaemia among inborn and outborn babies in a referral hospital | Q43767221 | ||
| Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India | Q44277397 | ||
| Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. | Q44426876 | ||
| The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. | Q44505244 | ||
| Prevalence and in-vitro antimicrobial susceptibility patterns of Acinetobacter strains isolated from patients in intensive care units | Q44578673 | ||
| Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units | Q46650511 | ||
| Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results | Q46942931 | ||
| Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors | Q46966792 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | India | Q668 |
| sepsis | Q183134 | ||
| blood culture | Q886695 | ||
| septicemia | Q1110041 | ||
| multiple drug resistance | Q643839 | ||
| Multidrug Resistance | Q58136246 | ||
| P304 | page(s) | 23-28 | |
| P1433 | published in | Journal of Laboratory Physicians | Q15817090 |
| P1476 | title | Multidrug-resistant septicemia in neonates: A study from a teaching hospital of Northern India | |
| P478 | volume | 11 |
| Q92541418 | Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections | cites work | P2860 |
Search more.